Series A - Dualyx
Investment Firm
Overview
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Announced Date
May 15, 2023
Funding Type
Series A
Highlights
Location
Europe
Social
Investor Lead
Andera Partners
Andera Partners is a early_stage_venture and late_stage_venture firm.
Forbion Capital Partners
Forbion Capital Partners is a early_stage_venture and post_ipo and seed firm.
Fountain Healthcare Partners
Fountain Healthcare Partners is a early_stage_venture and late_stage_venture and post_ipo and private_equity firm.
Participant Investors
8
Round Details and Background
Dualyx raised $43494004 on 2023-05-15 in Series A
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 01, 2020 |  Venture Round - Dualyx | 1 | - | undefined |
| May 15, 2023 | Series A - Dualyx | 9 | - | 43.5M |
Recent Activity
There is no recent news or activity for this profile.